Commissioner of corrections required to maintain a supply of opiate antagonists to administer to persons who overdose in correctional facilities, and commissioner required to provide training to employees on how to administer opiate antagonists.
HF1399 would require the Minnesota commissioner of corrections to keep a supply of opiate antagonists, such as naloxone, at every correctional facility so staff can respond quickly to opioid overdoses. The bill also directs the department to store enough nasal doses throughout each facility to allow rapid access in an emergency.
In addition to stocking the medication, the bill requires the commissioner, in consultation with the commissioner of health, to train correctional employees to recognize the symptoms of an opioid overdose and to administer nasal opiate antagonists. The proposal creates a new section in Minnesota Statutes chapter 241 and is aimed at standardizing overdose response practices in prisons and other correctional settings.
The bill would add a new statutory requirement in Minnesota corrections law, specifically proposed Minnesota Statutes section 241.76, mandating overdose-reversal medication and staff training in all correctional facilities. It would affect the Department of Corrections, facility administrators, and correctional employees by imposing operational and training obligations, and it would likely increase readiness to respond to opioid overdoses among incarcerated people and staff.
Based on the bill text alone and the absence of committee testimony or recorded votes, the measure appears to be a public-safety and health-oriented proposal with an emphasis on preventing overdose deaths in custody. The language is straightforward and administrative, suggesting a practical, preventive approach rather than a controversial policy change. No recorded discussion or vote history is available here to indicate broader support or opposition.
No committee transcripts or vote records were provided, so there is no documented disagreement to identify. Potential areas of concern, if raised in future debate, could include the cost of maintaining supplies, training requirements for staff, implementation across multiple facilities, and whether correctional settings should be treated differently from other public venues for overdose-response planning. However, none of these issues are reflected in the available record.